In 2022, German HealthTech had an exceptional year with the development and certification of the HYPA DiTA as a medical device. We are now the first company worldwide to offer a health DiTA HYPA with AI-backed therapy for hypertension type I-II.
About German HealthTech
We are making a contribution to make the world a better and healthier place. Our focus is on people, their well-being, and their health.
We develop medical solutions for 2.5 billion people that significantly improve life expectancy and quality of life, without medication and additives, without side effects, and climate-neutral.
Our Goal
We aim to prevent the world's most common diseases. In 2022, we developed our DiTA (Digital Therapy Application) HYPA and had it certified as a medical device. This makes us the first company worldwide to offer a health DiTA with AI-backed therapy for hypertension type I-II - a crucial step in the future of digital therapy.
The principle:
No side effects, through causal therapy for multivalent long-term success with the help of AI-guided digital medicine. Our products are CE approved and certified and authorized as medicines under EU guidelines. We have demonstrated the positive health effects of our products through evidence-based medicine and clinical studies. We have partnered with the University Hospitals of Giessen and Ulm for scientific support.
Company History
History and Future
We have taken a decisive step towards the future of treating common diseases with digital therapy, without side effects, causally and sustainably.
In 2023, our goal is to obtain certification for our second health DiTA SUGA, for supporting diabetes therapy, closing the circle and enabling us to positively influence the two most threatening common diseases worldwide. Through their multivalent mode of action, the two medical devices can positively impact the lives of 2.5 billion people.
Together with our scientific partners from the Universities of Giessen and Ulm, we have further developed our corporate culture to act ambitiously and responsibly, and to do what is right for humanity in line with our greatest health challenges.
German HealthTech has combined experience and scientific expertise to develop digital medical products that have a sustainable and positive impact on the lives and health of a large number of people worldwide, without any side effects or risks. We have taken action and done the right thing. At German HealthTech,
our goal is to positively impact the health of 2.5 billion people
over the next 10 years. We have four
strategic core areas on which we focus our investments:
Business areas and strategic core areas:
0
%
Prevention
- - Target group aged 20 to 40, is part of our company packages and is aimed at healthy individuals
0
%
DiTA
- - Development and approval of Digital Therapy Applications as CE medical products with approval as Class I medication I
- - Target group 40 to 75
0
%
CE medical devices HYPA, SUGA
- - International licensing business (EU countries with state health systems)
- - Package solutions for health insurance companies (GKV, PKV, BKK)
- - Companies (individualized health promotion for employees)
0
%
DiGA - Digital Health Applications
- - Are approved by the BfArM (Federal Institute for Drugs and Medical Devices)
- - Are covered by statutory and private health insurance companies upon prescription by a doctor
In these areas or strategic fields, we focus on beginning diseases with a great unmet medical need. We focus on patients between the ages of 20-40 with "prevention" and on patients between the ages of 40-65 with "therapy". Here, diseases are still fully reversible and the multivalent future scenarios can still be sustainably prevented upon the manifestation of the disease.
Our solution for...
Our premium product for you, the Digital Therapy Application (DiTA) called HYPA, is an officially approved medical device with CE certification of risk class I. With this DiTA, we are able to positively support your employees suffering from stage I and II hypertension. HYPA is based on the evidence-based fact that lifestyle modification based on "movement - nutrition - relaxation" positively influences blood pressure.
